Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $1.0 million.

  • Rockwell Medical's Capital Expenditures rose 19.90% to $229,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $851,000, marking a year-over-year increase of 29.14%. This contributed to the annual value of $1.0 million for FY2024, which is 255.99% up from last year.
  • As of FY2024, Rockwell Medical's Capital Expenditures stood at $1.0 million, which was up 255.99% from $284,000 recorded in FY2023.
  • Over the past 5 years, Rockwell Medical's Capital Expenditures peaked at $1.0 million during FY2020, and registered a low of $281,000 during FY2022.
  • In the last 3 years, Rockwell Medical's Capital Expenditures had a median value of $284,000 in 2023 and averaged $525,333.
  • Per our database at Business Quant, Rockwell Medical's Capital Expenditures slumped by 50.10% in 2021 and then spiked by 255.99% in 2024.
  • Over the past 5 years, Rockwell Medical's Capital Expenditures (Yearly) stood at $1.0 million in 2020, then crashed by 50.10% to $522,000 in 2021, then plummeted by 46.17% to $281,000 in 2022, then rose by 1.07% to $284,000 in 2023, then spiked by 255.99% to $1.0 million in 2024.